Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 04, 2020

SELL
$5.25 - $7.08 $845,250 - $1.14 Million
-161,000 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$4.23 - $8.29 $384,930 - $754,389
91,000 Added 130.0%
161,000 $1.21 Million
Q3 2019

Nov 12, 2019

BUY
$2.15 - $6.28 $150,500 - $439,600
70,000 New
70,000 $329,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $816M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Wisconsin Capital Management LLC Portfolio

Follow Wisconsin Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wisconsin Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wisconsin Capital Management LLC with notifications on news.